Moreover, several lipid metabolism-related genes (RETN, GPHN, ME1, LEP, LTC4S, DHCR7, TRIB3, MOSC2, ABCA1, and PPARG) ranked among the top dysregulated genes in APL patients versus non-APL AML patients. Here, ME1 is linked to acute myeloid leukemia.